Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Veradigm Inc (NQ: MDRX )

13.24 +0.10 (+0.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Veradigm Inc

< Previous 1 2 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
Earnings Preview For Veradigm
Via Benzinga
Veradigm Earnings Preview
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 64 companies achieved new lows for the year. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
Via Benzinga
4 Analysts Have This to Say About Veradigm
Via Benzinga
Analyst Ratings for Allscripts Healthcare
Allscripts Healthcare (NASDAQ:MDRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 141 companies reached new 52-week lows. 
Via Benzinga
Sector Spotlight: HealthCare Software Stocks For 2023
Sector Spotlight: HealthCare Software Stocks For 2023 
Via News Direct
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
Veradigm Takes Action with FY23 Outlook and Major Share Buyback Initiative
Via Benzinga
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Veradigm Stock Showing Improving Market Leadership; Earns 82 RS Rating
On Monday, medical software Veradigm stock had its Relative Strength (RS) Rating upgraded to 82, up from 79 a day earlier. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
U.S. Stock: Allscripts Healthcare Solutions
Allscripts Healthcare Solutions Incorporated is an American company that provides management and electronic health record technology for physician practices, hospitals, and other healthcare providers. 
Via Talk Markets
A Preview Of Allscripts Healthcare's Earnings
Allscripts Healthcare (NASDAQ:MDRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Where Allscripts Healthcare Stands With Analysts
Allscripts Healthcare (NASDAQ:MDRX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022
Upgrades According to Susquehanna, the prior rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) was changed from Neutral to Positive. Knight-Swift earned $1.61 in the... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Down; Jobs Report In Focus
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Nasdaq dipped more than 200 points in the previous session. The Zaporizhzhia nuclear power... 
Via Benzinga
Allscripts Divests Hospitals & Large Physician Practices Segment For $700M
Allscripts Healthcare Solutions (NASDAQ: MDRX) will sell its net assets of the Allscripts Hospitals and Large Physician Practices business segment to ... 
Via Benzinga
Allscripts Healthcare: Q4 Earnings Insights
Allscripts Healthcare (NASDAQ:MDRX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients... 
Via Benzinga
Allscripts Healthcare Solutions Inc. Climbs to Annual-High Share Price
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of Allscripts Healthcare... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.